We're absolutely delighted to win this award in recognition of our advocacy work on behalf of the blood cancer community - thanks to all those who contributed to the UK Blood Cancer Action Plan, and to the AMRC for their support 🏆

We've had insightful panel discussions throughout the day covering UK regulations, including recent changes, industry impacts, and opportunities for growth 🚀👏 Our first panel discussion panel chaired by Dr Martin O' Kane, Regional Head of Regulatory Affairs EU Policy & Liaison at Novartis and Member of the @BIA_UK Regulatory Affairs Advisory Committee ⤵ 📌 @rubina1402, Director of Research, Policy and Services, at @bloodcancer_uk 📌 Professor Lucy Chappell, Chief Scientific Advisor, Department of Health and Social Care, and Chief Executive, @NIHRresearch 📌 Clive Collett, Head of Policy and Engagement at the @HRA_Latest 📌 Lord @jamesosh, Senior Partner at, @jamesosh 📌 James Pound, Interim Executive Director of Innovation and Compliance at the @MHRApress 📌 Professor @SENSElabCamb, Professor of Otology and Skull Base Surgery at the @Cambridge_Uni Our second-panel session was on regulatory pathways and collaboration across the UK healthcare ecosystem. The panel was chaired by Tim Stonehouse, Vice President of International Regulatory Strategy at @VertexPharma and Chair of the @BIA_UK Regulatory Affairs Advisory Committee ⤵ 📌 Paul Smith, Vice President of Regulatory Affairs at @Infinitopes 📌 Julian Beach, Interim Executive Director of Healthcare Quality and Access at the @MHRApress 📌 @Louiseknowles5, Depity Director of the Innovation Accelerator and Regulatory Science at the @MHRApress 📌 John Spoors, Programme Director for Commercial, Managed Access and Medicines Policy, @NICEComms 📌 Jack Turner, Deputy Director of Medicines Access Policy at @NHSEngland Our final panel was chaired by Kathy Williams, Head of Global Regulatory Policy and Intelligence at @ASTRAZENECAUK and Vice-Chair of the @BIA_UK Regulatory Affairs Advisory Committee ⤵️ 📌 Dr Alison Cave, Chief Safety Officer at the @MHRApress 📌 Dr. Puja Myles, Director of the Clinical Practice Research Datalink (CPRD) at @MHRApress 📌 Dr. Gracy Crane, Regulatory Chapter Lead and Regulatory Science Lead (RWD) at @RocheDiaUK #UKLifeSciencesReg #LifeSciences

Exciting news – yesterday @SKinnock outlined the UK government's commitment to a National Cancer Plan. Blood cancer is the 5th most common cancer but as @CliveJonesMP said during the debate, historically there's been a lack of strategic direction in blood cancer policy.